Calidi Biotherapeutics Statistics

Total Valuation

CLDI has a market cap or net worth of $9.42 million. The enterprise value is $3.64 million.

Market Cap	9.42M
Enterprise Value	3.64M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

CLDI has 33.59 million shares outstanding. The number of shares has increased by 488.87% in one year.

Current Share Class	31.79M
Shares Outstanding	33.59M
Shares Change (YoY)	+488.87%
Shares Change (QoQ)	+77.16%
Owned by Insiders (%)	4.11%
Owned by Institutions (%)	8.31%
Float	27.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.43
P/TBV Ratio	1.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.64.

Current Ratio	2.12
Quick Ratio	1.96
Debt / Equity	0.64
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-26.71

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-111.74%
Return on Invested Capital (ROIC)	-274.58%
Return on Capital Employed (ROCE)	-208.40%
Revenue Per Employee	n/a
Profits Per Employee	-$770,536
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CLDI has paid $13,000 in taxes.

Income Tax	13,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.76% in the last 52 weeks. The beta is 1.06, so CLDI's price volatility has been similar to the market average.

Beta (5Y)	1.06
52-Week Price Change	-85.76%
50-Day Moving Average	0.41
200-Day Moving Average	1.02
Relative Strength Index (RSI)	26.47
Average Volume (20 Days)	586,112

Short Selling Information

The latest short interest is 294,158, so 0.88% of the outstanding shares have been sold short.

Short Interest	294,158
Short Previous Month	228,236
Short % of Shares Out	0.88%
Short % of Float	1.09%
Short Ratio (days to cover)	1.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-20.09M
Pretax Income	-29.96M
Net Income	-21.58M
EBITDA	-19.70M
EBIT	-20.09M
Earnings Per Share (EPS)	-$1.55

Full Income Statement

Balance Sheet

The company has $10.56 million in cash and $4.71 million in debt, giving a net cash position of $5.86 million or $0.17 per share.

Cash & Cash Equivalents	10.56M
Total Debt	4.71M
Net Cash	5.86M
Net Cash Per Share	$0.17
Equity (Book Value)	7.30M
Book Value Per Share	0.21
Working Capital	6.06M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$22.99 million and capital expenditures -$18,000, giving a free cash flow of -$23.01 million.

Operating Cash Flow	-22.99M
Capital Expenditures	-18,000
Free Cash Flow	-23.01M
FCF Per Share	-$0.69

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLDI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-488.87%
Shareholder Yield	-488.87%
Earnings Yield	-227.11%
FCF Yield	-242.23%

Analyst Forecast

The average price target for CLDI is $10.00, which is 3,465.06% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	3,465.06%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-43.85%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 15, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jul 15, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2